These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2785792)

  • 1. Inhibition of the covalent binding reaction of complement component C4 by penicillamine, an anti-rheumatic agent.
    Sim E; Dodds AW; Goldin A
    Biochem J; 1989 Apr; 259(2):415-9. PubMed ID: 2785792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of thiol compounds on human complement component C4.
    Edmonds S; Gibb A; Sim E
    Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):801-5. PubMed ID: 8435078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydralazine binds covalently to complement component C4. Different reactivity of C4A and C4B gene products.
    Sim E; Law SK
    FEBS Lett; 1985 May; 184(2):323-7. PubMed ID: 3873356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
    Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
    J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation.
    Sepp A; Dodds AW; Anderson MJ; Campbell RD; Willis AC; Law SK
    Protein Sci; 1993 May; 2(5):706-16. PubMed ID: 8495193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent binding properties of the C4A and C4B isotypes of the fourth component of human complement on several C1-bearing cell surfaces.
    Isenman DE; Young JR
    J Immunol; 1986 Apr; 136(7):2542-50. PubMed ID: 3512717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
    Isenman DE; Young JR
    J Immunol; 1984 Jun; 132(6):3019-27. PubMed ID: 6609966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glomerular deposition of the complement C4 isotypes C4A and C4B in glomeruonephritis.
    Lhotta K; Schlogl A; Kronenberg F; Joannidis M; Konig P
    Nephrol Dial Transplant; 1996 Jun; 11(6):1024-8. PubMed ID: 8671963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement-mediated adherence of immune complexes to human erythrocytes. Difference in the requirements for C4A and C4B.
    Schifferli JA; Hauptmann G; Paccaud JP
    FEBS Lett; 1987 Mar; 213(2):415-8. PubMed ID: 3493921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two isotypes of human C4, C4A and C4B have different structure and function.
    Schifferli JA; Paccaud JP
    Complement Inflamm; 1989; 6(1):19-26. PubMed ID: 2650988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the properties of two classes, C4A and C4B, of the human complement component C4.
    Law SK; Dodds AW; Porter RR
    EMBO J; 1984 Aug; 3(8):1819-23. PubMed ID: 6332733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of soluble human complement receptor type 1 (sCR1, BRL55730) with human complement component C4.
    Gibb AL; Freeman AM; Smith RA; Edmonds S; Sim E
    Biochim Biophys Acta; 1993 Jan; 1180(3):313-20. PubMed ID: 8422437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Difference in the biological properties of the two forms of the fourth component of human complement (C4).
    Schifferli JA; Steiger G; Paccaud JP; Sjöholm AG; Hauptmann G
    Clin Exp Immunol; 1986 Feb; 63(2):473-7. PubMed ID: 3486068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino acid residues 1101-1105 of the isotypic region of human C4B is important to the covalent binding activity of complement component C4.
    Reilly BD; Levine RP; Skanes VM
    J Immunol; 1991 Nov; 147(9):3018-23. PubMed ID: 1919003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.
    Carroll MC; Fathallah DM; Bergamaschini L; Alicot EM; Isenman DE
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6868-72. PubMed ID: 2395880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of nucleophilic compounds with complement component C4.
    Sim E; Wood M; Parker KE; Jones A
    Comp Immunol Microbiol Infect Dis; 1988; 11(3-4):163-70. PubMed ID: 3146461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of human C4A and C4B binding to an immune complex in serum.
    Reilly BD
    Clin Exp Immunol; 1999 Jul; 117(1):12-8. PubMed ID: 10403910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence showing that the 1105 and 1106 isotypic residues of the fourth component of human complement, C4A, are not involved in amide bond formation.
    Reilly BD; Skanes VM; Levine RP
    Mol Immunol; 1994 Jul; 31(10):761-9. PubMed ID: 7518568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deficiency of human complement protein C4 due to identical frameshift mutations in the C4A and C4B genes.
    Lokki ML; Circolo A; Ahokas P; Rupert KL; Yu CY; Colten HR
    J Immunol; 1999 Mar; 162(6):3687-93. PubMed ID: 10092831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relative roles of C4A and C4B in prevention of immune precipitation, solubilisation and immune adherence.
    Holme ER; Veitch J; Johnston A; McKay IC; Whaley K
    Rheumatol Int; 1992; 12(5):187-90. PubMed ID: 1290020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.